Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Cardiology Sequencing- Arrhythmia Comprehensive Panel (134 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 88 | 134 |
|
Cardiology Sequencing- Full Panel (174 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 122 | 174 |
|
Comprehensive Arrhythmia Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 36 | 44 |
|
Arrhythmogenic Cardiomyopathy Panel Mayo Clinic Laboratories Mayo Clinic United States | 26 | 18 |
|
Cardiomyopathy and Arrhythmia Panel Mayo Clinic Laboratories Mayo Clinic United States | 73 | 105 |
|
Comprehensive Cardiomyopathy Panel Mayo Clinic Laboratories Mayo Clinic United States | 68 | 83 |
|
Hypertrophic Cardiomyopathy Panel Mayo Clinic Laboratories Mayo Clinic United States | 44 | 48 |
|
Dilated Cardiomyopathy/LVNC Panel Mayo Clinic Laboratories Mayo Clinic United States | 52 | 63 |
|
Genetic Services Laboratory University of Chicago United States | 115 | 136 |
|
Genetic Services Laboratory University of Chicago United States | 115 | 136 |
|
Pan Cardiomyopathy Panel (62 Genes) Laboratory for Molecular Medicine Mass General Brigham Personalized Medicine United States | 100 | 61 |
|
Centogene US, LLC - The Rare Disease Company United States | 316 | 314 |
|
Centogene US, LLC - The Rare Disease Company United States | 289 | 275 |
|
Centogene US, LLC - The Rare Disease Company United States | 325 | 316 |
|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Invitae Rhabdomyolysis and Metabolic Myopathy Panel Invitae United States | 202 | 128 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.